Clinical trials
Nephrolithiasis trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2015 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 2 |
| Completed | 2 |
| Recruiting | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Calcilytix Therapeutics, Inc., a BridgeBio company | 2 |
| Mario Negri Institute for Pharmacological Research | 2 |
| IRCCS SYNLAB SDN | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
| University of Parma | 1 |
| University of Turin, Italy | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nephrolithiasis | 8 |
| Calcium Metabolism Disorders | 2 |
| Hypercalciuria | 2 |
| Hypocalcemia | 2 |
| Hypoparathyroidism | 2 |
| Metabolic Diseases | 2 |
| Muscular Diseases | 2 |
| Musculoskeletal Abnormalities | 2 |
| Musculoskeletal Diseases | 2 |
| Nephrocalcinosis | 2 |
Trials
Showing 76 to 8 of 8. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.